Suspension of trading

Bellicum Pharmaceuticals, Inc. Stock

Stocks

BPXA

US0794814048

Biotechnology & Medical Research

OTC Markets Traded
Market Closed - Börse Stuttgart 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Bellicum Pharmaceuticals, Inc. -2.31% -53.99%
3 years 0
Extreme 0
0.19
5 years 0
Extreme 0
0.19
10 years 0
Extreme 0
0.19
Manager TitleAgeSince
Chief Executive Officer 66 23/02/2024
Chief Executive Officer 57 31/01/2017
Director TitleAgeSince
Director/Board Member 57 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
22/11/23
Baker Bros. Advisors LP
OptionCompany 4,232,698 44.5721%
03/01/23Fiscal year

Director

80,968 0.9400%
03/01/23Fiscal year

Director

60,414 0.7014%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-2.31% - - 822K
-0.38%-3.44%+71.35%+128.83% 56.71B
+4.91%-0.19%+73.70%+92.14% 51.3B
+1.48%+5.97%+22.59%+495.47% 25.26B
-0.59%-4.68%-16.82%-12.99% 23.65B
+4.59%+3.35%+51.05%+2.16% 18.69B
+2.01%+2.99%+40.72%-24.93% 17.71B
-6.84%+2.18%+203.03%+348.11% 17.7B
+7.79%+1.90%+51.43% - 14.26B
+1.76%+2.24%+29.57%+195.70% 14.1B
Average +1.42%+1.98%+58.51%+153.06% 23.94B
Weighted average by Cap. +1.60%+0.75%+60.24%+145.52%

Financials

2021 2022
Net sales 6.2M 5.42M 5M 4.63M 8.78M 592M 8.93M 59.9M 23.48M 291M 23.28M 22.77M 1.01B 1.5M 1.31M 1.21M 1.12M 2.13M 143M 2.16M 14.49M 5.68M 70.31M 5.63M 5.51M 244M
Net income -9.7M -8.49M -7.83M -7.24M -13.75M -926M -13.98M -93.76M -36.75M -455M -36.43M -35.65M -1.58B -24.97M -21.85M -20.15M -18.64M -35.38M -2.38B -35.97M -241M -94.58M -1.17B -93.75M -91.72M -4.05B
Net Debt - -
Logo Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals Inc is a United States-based company. The Company operates as a biopharmaceutical company focused on discovering and developing cellular immunotherapies for various forms of cancer.
Employees
13
  1. Stock Market
  2. Stocks
  3. BPXA Stock